Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus.

Arquivos de gastroenterologia - 1 Jan 2000

Mattos Angelo Alves de, Gomes Eliana Buksztejn, Tovo Cristiane Valle, Alexandre Cláudio Osmar Pereira, Remião José Oscar dos Reis

Abstract excerpt

BACKGROUND: Considering the immunosuppression of patients with chronic liver disease, their response to vaccination is discussed in literature. AIMS: To evaluate the response of hepatitis B vaccine in patients with chronic hepatitis C virus infection. METHODS: This is a prospective study in which 85 patients with chronic hepatitis C virus infection (46.8 +/- 9.4 years, 44.7% males) and 46 healthy adults (36.7 +/-...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Chronic Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis B

Share to Hepatitis B Vaccines

Share to Hepatitis C, Chronic

Share to Treatment Outcome

Share to Viral Load

Source

Identifiers

PMID: 15678203
DOI: 10.1590/s0004-28032004000300008

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus.PMID 15678203Read ↗

Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines.Semantic proximity Read ↗

Hepatitis B vaccine: prophylactic, therapeutic, and diagnostic dilemma.Semantic proximity Read ↗

Prospects for prophylactic and therapeutic vaccines against hepatitis C virus.Semantic proximity Read ↗

Progress in the development of vaccines for hepatitis C virus infection.Semantic proximity Read ↗

Results of a phase III clinical trial with an HBsAg-HBIG immunogenic complex therapeutic vaccine for chronic hepatitis B patients: experiences and findings.Semantic proximity Read ↗

Hepatitis B virus vaccine failure resulting in chronic hepatitis B infection.Semantic proximity Read ↗

The global impact of vaccination against hepatitis B: a historical overview.Semantic proximity Read ↗

Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.Semantic proximity Read ↗

Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes.Semantic proximity Read ↗

A poxvirus vaccine is safe, induces T-cell responses, and decreases viral load in patients with chronic hepatitis C.Semantic proximity Read ↗

[Vaccination against hepatitis B virus: current data].Semantic proximity Read ↗

Long-term efficacy of a hepatitis E vaccine.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.